Obesity is a risk factor for non-alcoholic fatty liver disease, which leads to hepatocyte proliferation in response to liver damage; increased hepatocyte proliferation has been reported both in a mice model of obesity [43] and associated with mice ghrelin levels [44]. Here, GHRL is linked to metabolic dysfunction-associated steatotic liver disease.